Kwok-Yung Yuen to Drug Combinations
This is a "connection" page, showing publications Kwok-Yung Yuen has written about Drug Combinations.
Connection Strength
0.102
-
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet. 2020 05 30; 395(10238):1695-1704.
Score: 0.102